[{"address1": "401 Professional Drive", "address2": "Suite 260", "city": "Gaithersburg", "state": "MD", "zip": "20879", "country": "United States", "phone": "(240) 403-4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anatoly  Dritschilo M.D.", "age": 79, "title": "Co-Founder, CEO & Chairman of the Board", "yearBorn": 1944, "fiscalYear": 2023, "totalPay": 399175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter Dale Dritschilo M.B.A., M.D.", "age": 54, "title": "President & COO", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 314012, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milton  Brown CSC, M.D., Ph.D.", "age": 58, "title": "Co-Founder & Director", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael P. Vander Hoek", "age": 63, "title": "CFO and VP of Operations & Regulatory", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 302530, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tyvin A. Rich M.D.", "age": 75, "title": "Chief Clinical Officer & Chief Medical Officer", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": 263226, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mira  Jung Ph.D.", "age": 74, "title": "Co-Founder & Chief Scientific Officer for Biology", "yearBorn": 1949, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gene  Jung Esq.", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4351, "open": 0.44, "dayLow": 0.4202, "dayHigh": 0.4997, "regularMarketPreviousClose": 0.4351, "regularMarketOpen": 0.44, "regularMarketDayLow": 0.4202, "regularMarketDayHigh": 0.4997, "volume": 223913, "regularMarketVolume": 223913, "averageVolume": 67452, "averageVolume10days": 123840, "averageDailyVolume10Day": 123840, "bid": 0.3426, "ask": 0.5548, "bidSize": 200, "askSize": 200, "marketCap": 7725654, "fiftyTwoWeekLow": 0.35, "fiftyTwoWeekHigh": 1.01, "fiftyDayAverage": 0.4267202, "twoHundredDayAverage": 0.44370124, "currency": "USD", "enterpriseValue": 4822324, "floatShares": 9685279, "sharesOutstanding": 16794900, "sharesShort": 31014, "sharesShortPriorMonth": 37785, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.0018000001, "heldPercentInsiders": 0.45796, "heldPercentInstitutions": 0.01705, "shortRatio": 0.32, "shortPercentOfFloat": 0.003, "bookValue": 0.164, "priceToBook": 2.804878, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -7348657, "trailingEps": -0.47, "enterpriseToEbitda": -0.842, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SHPH", "underlyingSymbol": "SHPH", "shortName": "Shuttle Pharmaceuticals Holding", "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "firstTradeDateEpochUtc": 1661952600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7d533843-75d5-319f-b923-9ea3e624e2b7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.46, "recommendationKey": "none", "totalCash": 4187879, "totalCashPerShare": 0.249, "ebitda": -5725214, "totalDebt": 1284552, "quickRatio": 2.82, "currentRatio": 2.962, "debtToEquity": 46.517, "returnOnAssets": -0.47172, "returnOnEquity": -1.5202099, "freeCashflow": -2904725, "operatingCashflow": -5482248, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-19"}]